Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
retina
Research
Scientists turn pig semen extract into cancer-killing eye drops
In mice with retinoblastoma, eye drops made with exosomes from pig semen killed cancer cells, slowed tumor growth and saved the rodents’ retinas.
Darren Incorvaia
Mar 27, 2026 2:39pm
Lilly bags eye-catching gene therapy in $475M deal
Nov 10, 2025 7:00am
Boehringer inks another eye disease deal, this time with Palatin
Aug 18, 2025 10:30am
Atsena gene therapy hits safety goals, closes retinal splits
May 19, 2025 12:59pm
Regeneron snaps up eye biotech, snaring science but not staff
Jan 2, 2025 3:58pm
Atsena downsizes to funnel money toward new capsid program
Oct 5, 2023 1:47pm